372 related articles for article (PubMed ID: 32486152)
1. Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing.
Maule G; Arosio D; Cereseto A
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486152
[TBL] [Abstract][Full Text] [Related]
2. Genome Editing for Cystic Fibrosis.
Wang G
Cells; 2023 Jun; 12(12):. PubMed ID: 37371025
[TBL] [Abstract][Full Text] [Related]
3. Rewriting CFTR to cure cystic fibrosis.
Maule G; Ensinck M; Bulcaen M; Carlon MS
Prog Mol Biol Transl Sci; 2021; 182():185-224. PubMed ID: 34175042
[TBL] [Abstract][Full Text] [Related]
4.
Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
[TBL] [Abstract][Full Text] [Related]
5. New approaches to genetic therapies for cystic fibrosis.
Christopher Boyd A; Guo S; Huang L; Kerem B; Oren YS; Walker AJ; Hart SL
J Cyst Fibros; 2020 Mar; 19 Suppl 1():S54-S59. PubMed ID: 31948871
[TBL] [Abstract][Full Text] [Related]
6. Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis.
Schneider-Futschik EK
Gene Ther; 2019 Sep; 26(9):354-362. PubMed ID: 31300729
[TBL] [Abstract][Full Text] [Related]
7. Human Molecular Genetics and the long road to treating cystic fibrosis.
Harris A
Hum Mol Genet; 2021 Oct; 30(R2):R264-R273. PubMed ID: 34245257
[TBL] [Abstract][Full Text] [Related]
8. Treating Cystic Fibrosis with mRNA and CRISPR.
Da Silva Sanchez A; Paunovska K; Cristian A; Dahlman JE
Hum Gene Ther; 2020 Sep; 31(17-18):940-955. PubMed ID: 32799680
[TBL] [Abstract][Full Text] [Related]
9. Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis.
Villate-Beitia I; Zarate J; Puras G; Pedraz JL
Drug Dev Ind Pharm; 2017 Jul; 43(7):1071-1081. PubMed ID: 28270008
[TBL] [Abstract][Full Text] [Related]
10. Gene and Base Editing as a Therapeutic Option for Cystic Fibrosis-Learning from Other Diseases.
Mention K; Santos L; Harrison PT
Genes (Basel); 2019 May; 10(5):. PubMed ID: 31117296
[TBL] [Abstract][Full Text] [Related]
11. Emerging technologies for cystic fibrosis transmembrane conductance regulator restoration in all people with CF.
Egan ME
Pediatr Pulmonol; 2021 Feb; 56 Suppl 1(Suppl 1):S32-S39. PubMed ID: 32681713
[TBL] [Abstract][Full Text] [Related]
12. A sheep model of cystic fibrosis generated by CRISPR/Cas9 disruption of the CFTR gene.
Fan Z; Perisse IV; Cotton CU; Regouski M; Meng Q; Domb C; Van Wettere AJ; Wang Z; Harris A; White KL; Polejaeva IA
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282831
[TBL] [Abstract][Full Text] [Related]
13. In vivo editing of lung stem cells for durable gene correction in mice.
Sun Y; Chatterjee S; Lian X; Traylor Z; Sattiraju SR; Xiao Y; Dilliard SA; Sung YC; Kim M; Lee SM; Moore S; Wang X; Zhang D; Wu S; Basak P; Wang J; Liu J; Mann RJ; LePage DF; Jiang W; Abid S; Hennig M; Martinez A; Wustman BA; Lockhart DJ; Jain R; Conlon RA; Drumm ML; Hodges CA; Siegwart DJ
Science; 2024 Jun; 384(6701):1196-1202. PubMed ID: 38870301
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation.
Santos L; Mention K; Cavusoglu-Doran K; Sanz DJ; Bacalhau M; Lopes-Pacheco M; Harrison PT; Farinha CM
J Cyst Fibros; 2022 Jan; 21(1):181-187. PubMed ID: 34103250
[TBL] [Abstract][Full Text] [Related]
15. Correction of Airway Stem Cells: Genome Editing Approaches for the Treatment of Cystic Fibrosis.
King NE; Suzuki S; Barillà C; Hawkins FJ; Randell SH; Reynolds SD; Stripp BR; Davis BR
Hum Gene Ther; 2020 Sep; 31(17-18):956-972. PubMed ID: 32741223
[TBL] [Abstract][Full Text] [Related]
16. Gene editing flows to the lungs.
Bulcaen M; Carlon MS
Science; 2024 Jun; 384(6701):1175-1176. PubMed ID: 38870313
[TBL] [Abstract][Full Text] [Related]
17. A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies.
McHugh DR; Steele MS; Valerio DM; Miron A; Mann RJ; LePage DF; Conlon RA; Cotton CU; Drumm ML; Hodges CA
PLoS One; 2018; 13(6):e0199573. PubMed ID: 29924856
[TBL] [Abstract][Full Text] [Related]
18. New horizons for cystic fibrosis treatment.
Fajac I; De Boeck K
Pharmacol Ther; 2017 Feb; 170():205-211. PubMed ID: 27916649
[TBL] [Abstract][Full Text] [Related]
19. Animal and model systems for studying cystic fibrosis.
Rosen BH; Chanson M; Gawenis LR; Liu J; Sofoluwe A; Zoso A; Engelhardt JF
J Cyst Fibros; 2018 Mar; 17(2S):S28-S34. PubMed ID: 28939349
[TBL] [Abstract][Full Text] [Related]
20. P.F508del editing in cells from cystic fibrosis patients.
Smirnikhina SA; Kondrateva EV; Adilgereeva EP; Anuchina AA; Zaynitdinova MI; Slesarenko YS; Ershova AS; Ustinov KD; Yasinovsky MI; Amelina EL; Voronina ES; Yakushina VD; Tabakov VY; Lavrov AV
PLoS One; 2020; 15(11):e0242094. PubMed ID: 33175893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
